CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration

Journal of Immunology

Volumn 170, Issue 11, 2003, Pages 5658-5666

  Anders, Hans Joachim ^a   Frink, Michael ^a   Linde, Yvonne ^a   Banas, Bernard ^a   Wörnle, Markus ^a   Cohen, Clemens D ^a   Vielhauer, Volker ^a   Nelson, Peter J ^a   Gröne, Hermann Josef ^b   Schlöndorff, Detlef ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOOXYPENTANE RANTES; APOFERRITIN; BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; IMMUNOGLOBULIN G; INDUCIBLE NITRIC OXIDE SYNTHASE; INHIBITOR PROTEIN; LIGAND; METHIONINE RANTES; NITRIC OXIDE SYNTHASE; RANTES; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS; HUMORAL IMMUNITY; IMMUNE COMPLEX DEPOSITION; IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MACROPHAGE; MESANGIUM; MOUSE; NEPHROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; TH1 CELL; TH2 CELL; UPREGULATION;

EID: 0037514185     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.11.5658     Document Type: Article

References (46)

1. Atkins. R. C. 1998. Macrophages in renal injury. Am. J. Kidney Dis. 31:95.
2. D'Souza, M. J., C. W. Oettinger, A. Shah, P. G. Tipping, X. R. Huang, and G. V. Milton. 1999. Macrophage depletion by albumin microencapsulated clodronate: attenuation of cytokine release in macrophage-dependent glomerulonephritis. Drug. Dev. Ind. Pharm. 25:591.
3. Holdsworth, S. R. 1983. Fc dependence of macrophage accumulation and subsequent injury in experimental glomerulonephritis. J. Immunol. 130:735.
4. Rollins, B. J. 1997. Chemokines. Blood 90:909.
5. Natori, Y., M. Sekiguchi, Z. Ou, and Y. Natori. 1997. Gene expression of CC chemokines in experimental crescentic glomerulonephritis (CGN). Clin. Exp. Immunol. 109:143.
6. Tang, W. W., S. Yin, A. J. Wittwer, and M. Qi. 1995. Chemokine gene expression in anti-glomerular basement membrane antibody glomerulonephritis. Am. J. Physiol. 269:F323.
7. Tang, W. W., M. Qi, and J. S. Warren. 1996. Monocyte chemoattractant protein-1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int. 50:665.
8. Schadde, E., M. Kretzler, B. Banas, B. Luckow, K. Assmann, and D. Schlöndorff. 2000. Expression of chemokines and their receptors in nephrotoxic serum nephritis. Nephrol. Dial. Transplant. 15:1046.
9. Perez de Lema, G., H. Maier, E. Nieto, V. Vielhauer, B. Luckow, F. Mampaso, and D. Schlöndorff. 2001. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J. Am. Soc. Nephrol. 12:1369.
10. Lloyd. C. M., A. W. Minto, M. E. Dorf, A. Proudfoot, T. N. Wells, D. J. Salant, and J. C. Gutierrez-Ramos. 1997. RANTES and monocyte chemoattractant protein-1 (MCP-1) p]ay an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J. Exp. Med. 185:1371.
11. Wada, T., H. Yokoyama, K. Furuichi, K. I. Kobayashi, K. Harada, M. Naruto, S. B. Su, M. Akiyama, N. Mukaida, and K. Matsushima. 1996. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J. 10:1418.
12. Schwarz, M. K., and T. N. Wells. 2002. New therapeutics that modulate chemokine networks. Nat. Rev. Drug Discov. 1:347.
13. Proudfoot, A. E. 2002. Chemokine receptors: multifaceted therapeutic targets, Nat. Rev. Immunol. 2:106.
14. Thelen, M. 2001. Dancing to the tune of chemokines. Nat. Immunol. 2:129.
15. Rovin, B. H. 2000. Chemokine blockade as a therapy for renal disease. Curr. Opin. Nephrol. Hypertens. 9:225.
16. Anders H. J., V. Vielhauer, and D. Schlöndorff. 2003. Chemokines and chemokine receptors are involved in the resolution and progression of renal disease: therapeutic implications. Kidney Int. 63:401.
17. Gerard. C., and B. J. Rollins. 2001. Chemokines and disease. Nat. Immunol. 2:108.
18. Topham, P. S., V. Csizmadia, D. Soler, D. Hines, C. J. Gerard, D. J. Salant, and W. W. Hancock. 1999. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J. Clin. Invest. 104:1549.
19. Anders, H. J., V. Vielhauer, D. C. Cohen, M. Kretzler, S. Segerer. B. Luckow, L. Weller, H. J. Gröne, and D. Schlöndorff. 2001. Chemokine and chemokine receptor expression during immune complex glomerulonephritis. J. Am. Soc. Nephrol. 12:919.
20. Proudfoot, A. E., R. Buser, F. Borlat, S. Alouani, D. Soler, R. E. Offord, J. M. Schroder, C. A. Power. and T. N. Wells. 1999. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors. J. Biol. Chem. 274:32478.1.
21. Gröne, H. J., C. Weber, K. S. Weber, E. F. Gröne, T. Rabelink, C. M. Klier, T. N. Wells, A. E. Proudfoot, D. Schlöndorff, and P. J. Nelson. 1999. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J. 13:1371.
22. Song, E., H. Zou, Y. Yao, A. Proudfoot, B. Antus, S. Liu, L. Jens, and U. Heemann. 2002. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int. 61:676.
23. Panzer, U., A. Schneider, J. Wilken, D. A. Thompson, S. B. Kent, and R. A. Stahl. 1999. The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney Int. 56:2107.
24. Nelson, P. J. 2000. The production of chemokine specific monoclonal antibodies: chemokine RANTES. Methods Mol. Biol. 138:223.
25. Hess, K. L., G. F. Babcock, D. S. Askew, and J. M. Cook-Mills. 1997. A novel flow cytometric method for quantifying phagocytosis of apoptotic cells. Cytometry 27:145.
26. Satriano, R. A., M. Shuldiner, K. Hora, Y. Xing, Z. Shan, and D. Schlöndorff. 1993. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G: evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J. Clin. Invest. 92:1564.
27. von Hundelshausen, P., K. S. Weber, Y. Huo, A. E. Proudfoot, P. J. Nelson, K. Ley, and C. Weber. 2001. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103:1772.
28. Yang, N., N. M. Isbel, D. J. Nikolic-Paterson, Y. Li, R. Ye, R. C. Atkins, and H. Y. Lan. 1998. Local macrophage proliferation in human glomerulonephritis. Kidney Int. 54:143.
29. Holdsworth, S. R., A. R. Kitching, and P. G. Tipping. 1999. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int. 55:1198.
30. Stoy, N. 2001. Macrophage biology and pathobiology in the evolution of immune responses: A functional analysis. Pathobiology 69:179.
31. Erwig, L. P., and A. J. Rees. 1999. Macrophage activation and programming and its role for macrophage function in glomerular inflammation. Kidney Blood Press. Res. 22:21.
32. Erwig, L. P., K. Stewart, and A. J. Rees. 2000. Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines. Am. J. Pathol. 156:295.
33. Erwig, L. P., K. S. K. Hill, and A. J. Rees. 2000. Exposure to chemokines differentially alters macrophage development in response to IFN-γ. J. Am. Soc. Nephrol. 11:A2570.
34. Rutherford, M. S., A. Witsell, and L. B. Schook. 1993. Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J. Leukocyte Biol. 53:602.
35. van Rooijen, N., and A. Sanders. 1997. Elimination, blocking, and activation of macrophages: three of a kind? J. Leukocyte Biol. 62:702.
36. Villalta, F., Y. Zhang, K. E. Bibb, J. C. Kappes, and M. F. Lima. 1998. The cysteine-cysteine family of chemokines RANTES, MIP-1α, and MIP-1β induce trypanocidal activity in human macrophages via nitric oxide. Infect. Immun. 66:4690.
37. Mellado, M., J. M. Rodriguez-Frade, S. Manes, and A. C. Martinez. 2001. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu. Rev. Immunol. 19:397.
38. Rodriguez-Frade, J. M., A. J. Vila-Coro, A. Martin, M. Nieto, F. Sanchez-Madrid, A. E. Proudfoot, T. N. Wells, A. C. Martinez, and M. Mellado. 1999. Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: implications for chemotaxis. J. Cell Biol. 144:755.
39. Dell'Albani, P., R. Santangelo, L. Torrisi, V. G. Nicoletti, J. de Vellis, and A. M. Giuffrida Stella. 2001. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J. Neurosci. Res. 65:417.
40. Hortelano, S., M. J. Diaz-Guerra, A. Gonzalez-Garcia, E. Leonardo, C. Gamallo, L. Bosca, and A. C. Martinez. 1997. Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL/Mp-lpr/lpr mice. J. Immunol. 158:1402.
41. Duffield, J. S., L. P. Erwig, X. Wei, F. Y. Liew, A. J. Rees, and J. S. Savill. 2000. Activated macrophages direct apoptosis and suppress mitosis of mesangial cells. J. Immunol. 164:2110,
42. Brune, B. 2002. Nitric oxide and apoptosis in mesangial cells. Kidney Int. 61:786.
43. Huynh, M. L., V. A. Fadok, and P. M. Henson. 2002. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest. 109:41.
44. Savill, J. 2001. Phagocyte clearance of cells dying by apoptosis and the regulation of glomerular inflammation. Adv. Nephrol. Necker Hosp. 31:21.
45. Moxey-Mims, M. M., and B. Noble. 1994. Glomerular macrophage phagocytic activity in experimental immune complex nephritis. Kidney Int. 45:1326.
46. Frink, M., H. J. Anders, Y. Linde. and D. Schlöndorff, 2001. RANTES antagonists induce mesangiolysis and nephrotic range proteinuria in murine immune complex glomerulonephritis: role of Th1/Th2 balance and macrophage function. J. Am. Soc. Nephrol. 12:A3390.